Ups/Downs
Dermira Inc (DERM): Hit Me Baby One More Time
Shares of Dermira Inc (NASDAQ:DERM) plunged hard Monday, after the drug maker announced negative Phase 3 data for its acne drug, DRM01, thus leading …
Dermira Inc (DERM): This Analyst Says Don’t Expect the Stock to Work in 2018
Dermira loses a bull after not one, but two pivotal studies of DRM01 in acne bombed.
James Jang Downgrades Pyxis Tankers Inc (PXS) on Valuation After Stunning Stock Rally
Pyxis Tankers stock reached the $9 level for the first time ever, sending Maxim’s James Jang to the exit.
The Downgrade That Broke Square Inc Rally
Square Inc (NYSE:SQ) has been Wall Street’s biggest standout of 2017, with shares skyrocketing nearly 260%. The biggest question for investors, then, is whether …
MannKind Corporation (MNKD) Shares Slide as Maxim Heads to Sidelines
MannKind’s capital raise is not enough, says Jason Kolbert.
Analysts Punish Otonomy Inc (OTIC) in Wake of Meniere’s Disease Drug Failure
Wednesday turned out to be a nightmare for Otonomy Inc (NASDAQ:OTIC) investors, after the drug maker announced disappointing results from a pivotal Phase …
Party Pooper: Standpoint Research Downgrades DSW Inc. Shares
Standpoint Research Moves to Sidelines as DSW Delivers Upbeat Earnings
Healthcare Sell-Side Analysts Head to Sidelines on CoLucid Pharmaceuticals Inc (CLCD) and Alcobra Ltd (ADHD)
CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the migraine-medicine maker announced a definitive merger agreement with Eli …
Here’s Why Cempra Inc (CEMP) Shares Are Falling 9% Today
Cempra Inc (NASDAQ:CEMP) seen its shares falling nearly 9% (as of this writing), after analyst Ritu Baral of investment banking firm Cowen has downgraded CEMP …
Here’s Why Needham Downgraded Cempra Inc (CEMP) Shares Today
In a research report released Friday, Needham analyst Alan Carr downgraded shares of Cempra Inc (NASDAQ:CEMP) from Buy to Hold rating, as he sees management …